Abstract
Objective
To evaluate the role of surgery in the treatment of the patients with non-small cell lung cancer with pleural dissemination.
Methods
The clinical records of 25 patients (mean age 69 years) diagnosed with carcinomatous pleuritis during a thoracotomy by pathological examination and followed by surgery between 1994 and 2012 were reviewed. The treatment modality, including surgery, the clinicopathologic characteristics and 5-year survival were analyzed.
Results
There were 16 adenocarcinomas, 6 squamous cell carcinomas and 3 large cell carcinomas. Surgery included resection of the main tumor by partial resection in 10 cases, segmentectomy in 2 cases, lobar resection in 12 cases and bilobectomy in 1 case. Intrathoracic irrigation was performed in 20 cases. The pathological N status was N0/N1/N2/Nx: 10/6/7/2. Fifteen patients received adjuvant therapy. The overall 5-year survival rate was 22.2 %. The 5-year survival rates of the N0, N1 and N2 groups were 36.0, 16.7 and 14.3 %, respectively (p = 0.0068). Nine patients lived more than 3 years including 5 in N0, 3 in N1 and 1 in N2.
Conclusions
Surgery should not be excluded from the multi-modality treatment of patients with carcinomatous pleuritis because there are some patients who could benefit from surgery especially if they are in N0 status.
Similar content being viewed by others
References
Rami-Porta R, Goldstraw P. The revised TNM staging system. Ann Thorac Cardiovasc Surg. 2009;15:4–9.
Reshad K, Inui K, Takeuchi Y, Takahashi Y, Hitomi S. Treatment of malignant pleural effusion. Chest. 1985;88:393–7.
Ichinose Y, Tsuchiya R, Koike T, Kuwahara O, Nakagawa K, Yamato Y, et al. and the Japan Clinical Oncology Group. The prognosis of patients with non-small cell lung cancer found to have carcinomatous pleuritis at thoracotomy. Surg Today. 2000;30:1062–6.
Sawabata N, Matsumura A, Motohiro A, Osaka Y, Gennga K, et al. for The Japan National Chest Hospital Study Group for Lung Cancer. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: Is tumor resection beneficial for prognosis? Ann Thorac Surg. 2002;73:412–5.
Ichinose Y, Tsuchiya R, Koike T, Kuwahara O, Nakagawa K, Yamato Y, et al. and the Japan Clinical Oncology Group. Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease. Lung Cancer. 2001;32:55–60.
Riquet M. Lung cancer with pleural dissemination: why not operation? Ann Thorac Surg. 2002;74:1750.
Ohta Y, Shimizu Y, Matsumoto Tamura M, Oda M, Watanabe G. Retrospective review of lung cancer patients with pleural dissemination after limited operations combined with parietal pleurectomy. J Surg Oncol. 2005;91:237–42.
The Japan Lung Cancer Society. General rule for clinical and pathological record of lung cancer (in Japanese). 7th ed; 2010. p. 50–1.
Kodama K, Doi O, Higashiyama M, Yokouchi H, Tatsuta M. Long-term results of postoperative intrathoracic chemo-thermotherapy for lung cancer with pleural dissemination. Cancer. 1993;72(2):426–31.
Yokoi K, Matsuguma H, Anraku M. Extrapleural pneumonectomy for lung cancer with carcinomatous pleuritis. J Thorac Cardiovasc Surg. 2002;123(1):184–5.
Pagan V, Fontana P, Zaccaria A, Lo Giudice F, Oniga F. Surgical outcome of lung cancer patients with carcinomatous pleuritis. Chir Ital. 2005;57(6):703–8.
Mordant P, Arame A, Foucault C, Dujon A, Le Pimpec Barthes F, Riquet M. Surgery for metastatic pleural extension of non-small-cell lung cancer. Eur J Cardiothorac Surg. 2011;40(6):1444–9.
Manac’h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg. 2001;71(4):1088–93.
Okada M, Sakamoto T, Nishio W, Uchino K, Tsuboshima K, Tsubota N. Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections. J Thorac Cardiovasc Surg. 2003;126(6):1911–5.
Buhr J, Berghäuser KH, Gonner S, Kelm C, Burkhardt EA, Padberg WM. The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer. J Thorac Cardiovasc Surg. 1997;113(4):683–90.
Kondo H, Asamura H, Suemasu K, Goya T, Tsuchiya R, Naruke T, et al. Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer. J Thorac Cardiovasc Surg. 1993;106(6):1092–7.
Buhr J, Berghäuser KH, Morr H, Dobroschke J, Ebner HJ. Tumor cells in intraoperative pleural lavage. An indicator for the poor prognosis of bronchogenic carcinoma. Cancer. 1990;65(8):1801–4.
Miura T, Shimada T, Tanaka K, Chujo M, Uchida Y. Lymphatic drainage of carbon particles injected into the pleural cavity of the monkey, as studied by video-assisted thoracoscopy and electron microscopy. J Thorac Cardiovasc Surg. 2000;120(3):437–47.
Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Takenaka A, et al. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with during long-term follow-up. Eur J Cardiothorac Surg. 2009;35(2):337–42.
Aokage K, Yoshida J, Ishii G, Enatsu S, Hishida T, Nishimura M, et al. The impact on survival of positive intraoperative pleural lavage cytology in patients with non-small-cell lung cancer. J Thorac Cardiovasc Surg. 2010;139(5):1246–52.
Satoh Y, Hoshi R, Ishikawa Y, Horai T, Okumura S, Nakagawa K. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology. Ann Thorac Surg. 2007;83(1):197–202.
Janjigian YY, Park BJ, Zakowski MF, Ladanyi M, Pao W, D’Angelo SP, et al. Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations. J Thorac Oncol. 2011;6(3):569–75.
Acknowledgments
This study received no financial support from any funds or institutes.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Go, T., Misaki, N., Matsuura, N. et al. Role of surgery in multi-modality treatment for carcinomatous pleuritis in patients with non-small cell lung cancer. Surg Today 45, 197–202 (2015). https://doi.org/10.1007/s00595-014-0987-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-014-0987-0